Market revenue in 2022 | USD 314.6 million |
Market revenue in 2030 | USD 590.6 million |
Growth rate | 8.2% (CAGR from 2022 to 2030) |
Largest segment | Dogs |
Fastest growing segment | Equine |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dogs, Equine, Cats, Other Animal type |
Key market players worldwide | Merck & Co Inc, CEVA Inc, Vetoquinol SA, Zoetis, Boehringer Ingelheim, IDEXX Laboratories Inc, Elanco Animal Health Inc, Indian Immunologicals, Virbac SA, Norbrook |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to companion animal health market will help companies and investors design strategic landscapes.
Dogs was the largest segment with a revenue share of 38.87% in 2022. Horizon Databook has segmented the Netherlands companion animal health market based on dogs, equine, cats, other animal type covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Netherlands companion animal health market , including forecasts for subscribers. This country databook contains high-level insights into Netherlands companion animal health market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account